Cheryl, thanks for the thoughtful post. I agree with your concept that the impact of the market can be more important than what is happening at an individual company. I also agree that the Asian crisis effects have a wider range or impact than some like myself may have assumed. I do not know that the information you have on Asians having been big buyers of biotech stocks is correct. I would be interested in the source. Even so, I think it is difficult to ignore the fact that money is fungible. So even if their investments were in Treasuries a repatriation of these funds would impact the stock market, including biotechs. But, the repatriation theory has yet to be proven. The weaker ones home economy gets the more it seems, in practice, those that are able to, get their money out. Yes, the flow out probably slows down as they earn less, but fear goes up, so even this is not clear cut. I guess any crisis impacts most sectors and only after it's over can one look back to find those that were not hurt and understand why they weren't.
BTW TSC mentions what some "experts" are looking at as potential buys. Biotecs were mentioned by two of those quoted. BTW James Cramer, of TSC, does not like biotechs. LGND was not mentioned nor any of the stocks I have followed.
thestreet.com |
